News Plus Therapeutics Receives $1.9 Million Advance Payment from CPRIT and Plans to Present at the CPRIT Innovations in Cancer Prevention and Research Conference Staff September 11, 2023 Iframe sync Post navigation Previous: Veru Reports Clinical Data from the Discontinued ARTEST Study of Enobosarm, Novel Selective Androgen Receptor Targeting Agonist, in AR+ ER+ HER2- Metastatic Breast CancerNext: Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19Â More Stories Clinical Trial Healthcare News Pharmaceutical Medicure Reports Financial Results for Quarter Ended September 30, 2026 and Schedules November 23, 2026 Conference Call Staff November 19, 2026 Cancer Healthcare News Pharmaceutical Dr. David Allison Details Post-Surgery Instructions Following Abdominoplasty Staff November 19, 2026 EHR Healthcare Hospitals News Pharmaceutical Veterans MEDHOST and IntelEDI Announce Partnership to Advance Revenue Cycle Automation Staff November 19, 2026